nodes	percent_of_prediction	percent_of_DWPC	metapath
Famotidine—Upper respiratory tract infection—Irinotecan—colon cancer	0.00591	0.00591	CcSEcCtD
Famotidine—Depression—Vincristine—colon cancer	0.00581	0.00581	CcSEcCtD
Famotidine—Extravasation—Methotrexate—colon cancer	0.00579	0.00579	CcSEcCtD
Famotidine—Pancytopenia—Fluorouracil—colon cancer	0.00579	0.00579	CcSEcCtD
Famotidine—Ear pain—Capecitabine—colon cancer	0.00578	0.00578	CcSEcCtD
Famotidine—Upper respiratory tract infection—Fluorouracil—colon cancer	0.00566	0.00566	CcSEcCtD
Famotidine—Photosensitivity—Capecitabine—colon cancer	0.00561	0.00561	CcSEcCtD
Famotidine—Swelling—Capecitabine—colon cancer	0.00559	0.00559	CcSEcCtD
Famotidine—Photosensitivity reaction—Fluorouracil—colon cancer	0.00556	0.00556	CcSEcCtD
Famotidine—Jaundice—Irinotecan—colon cancer	0.00553	0.00553	CcSEcCtD
Famotidine—Libido decreased—Capecitabine—colon cancer	0.00531	0.00531	CcSEcCtD
Famotidine—Hallucination—Vincristine—colon cancer	0.0052	0.0052	CcSEcCtD
Famotidine—Bradycardia—Irinotecan—colon cancer	0.00519	0.00519	CcSEcCtD
Famotidine—Sinusitis—Fluorouracil—colon cancer	0.0051	0.0051	CcSEcCtD
Famotidine—Agranulocytosis—Fluorouracil—colon cancer	0.00507	0.00507	CcSEcCtD
Famotidine—Pain in extremity—Capecitabine—colon cancer	0.00493	0.00493	CcSEcCtD
Famotidine—Disturbance in sexual arousal—Capecitabine—colon cancer	0.00489	0.00489	CcSEcCtD
Famotidine—Migraine—Capecitabine—colon cancer	0.00485	0.00485	CcSEcCtD
Famotidine—Pharyngitis—Fluorouracil—colon cancer	0.00484	0.00484	CcSEcCtD
Famotidine—Face oedema—Capecitabine—colon cancer	0.00476	0.00476	CcSEcCtD
Famotidine—Flushing—Irinotecan—colon cancer	0.00473	0.00473	CcSEcCtD
Famotidine—Irritability—Capecitabine—colon cancer	0.0047	0.0047	CcSEcCtD
Famotidine—Alopecia—Vincristine—colon cancer	0.00462	0.00462	CcSEcCtD
Famotidine—Mental disorder—Vincristine—colon cancer	0.00458	0.00458	CcSEcCtD
Famotidine—Arrhythmia—Irinotecan—colon cancer	0.00455	0.00455	CcSEcCtD
Famotidine—Gynaecomastia—Methotrexate—colon cancer	0.00452	0.00452	CcSEcCtD
Famotidine—Dry skin—Capecitabine—colon cancer	0.00452	0.00452	CcSEcCtD
Famotidine—Alopecia—Irinotecan—colon cancer	0.0045	0.0045	CcSEcCtD
Famotidine—Toxic epidermal necrolysis—Capecitabine—colon cancer	0.00444	0.00444	CcSEcCtD
Famotidine—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.00444	0.00444	CcSEcCtD
Famotidine—Back pain—Vincristine—colon cancer	0.0044	0.0044	CcSEcCtD
Famotidine—Arrhythmia—Fluorouracil—colon cancer	0.00436	0.00436	CcSEcCtD
Famotidine—Alopecia—Fluorouracil—colon cancer	0.00431	0.00431	CcSEcCtD
Famotidine—Back pain—Irinotecan—colon cancer	0.00429	0.00429	CcSEcCtD
Famotidine—Muscle spasms—Irinotecan—colon cancer	0.00426	0.00426	CcSEcCtD
Famotidine—Influenza—Capecitabine—colon cancer	0.00426	0.00426	CcSEcCtD
Famotidine—Anaemia—Vincristine—colon cancer	0.00421	0.00421	CcSEcCtD
Famotidine—Bronchospasm—Capecitabine—colon cancer	0.00419	0.00419	CcSEcCtD
Famotidine—Agitation—Vincristine—colon cancer	0.00418	0.00418	CcSEcCtD
Famotidine—Photosensitivity—Methotrexate—colon cancer	0.00418	0.00418	CcSEcCtD
Famotidine—Anaemia—Irinotecan—colon cancer	0.0041	0.0041	CcSEcCtD
Famotidine—Bronchitis—Capecitabine—colon cancer	0.0041	0.0041	CcSEcCtD
Famotidine—Abdominal discomfort—Capecitabine—colon cancer	0.00408	0.00408	CcSEcCtD
Famotidine—Leukopenia—Vincristine—colon cancer	0.00408	0.00408	CcSEcCtD
Famotidine—Pancytopenia—Capecitabine—colon cancer	0.00404	0.00404	CcSEcCtD
Famotidine—Neutropenia—Capecitabine—colon cancer	0.00398	0.00398	CcSEcCtD
Famotidine—Dysuria—Capecitabine—colon cancer	0.00398	0.00398	CcSEcCtD
Famotidine—Syncope—Irinotecan—colon cancer	0.00398	0.00398	CcSEcCtD
Famotidine—Leukopenia—Irinotecan—colon cancer	0.00397	0.00397	CcSEcCtD
Famotidine—Upper respiratory tract infection—Capecitabine—colon cancer	0.00396	0.00396	CcSEcCtD
Famotidine—Convulsion—Vincristine—colon cancer	0.00394	0.00394	CcSEcCtD
Famotidine—Anaemia—Fluorouracil—colon cancer	0.00393	0.00393	CcSEcCtD
Famotidine—Loss of consciousness—Irinotecan—colon cancer	0.0039	0.0039	CcSEcCtD
Famotidine—Photosensitivity reaction—Capecitabine—colon cancer	0.00389	0.00389	CcSEcCtD
Famotidine—Myalgia—Vincristine—colon cancer	0.00388	0.00388	CcSEcCtD
Famotidine—Cough—Irinotecan—colon cancer	0.00387	0.00387	CcSEcCtD
Famotidine—Leukopenia—Fluorouracil—colon cancer	0.0038	0.0038	CcSEcCtD
Famotidine—Depression—Capecitabine—colon cancer	0.00379	0.00379	CcSEcCtD
Famotidine—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.00376	0.00376	CcSEcCtD
Famotidine—Anaphylactic shock—Vincristine—colon cancer	0.00372	0.00372	CcSEcCtD
Famotidine—Oedema—Vincristine—colon cancer	0.00372	0.00372	CcSEcCtD
Famotidine—Jaundice—Capecitabine—colon cancer	0.0037	0.0037	CcSEcCtD
Famotidine—Infection—Vincristine—colon cancer	0.00369	0.00369	CcSEcCtD
Famotidine—Convulsion—Fluorouracil—colon cancer	0.00368	0.00368	CcSEcCtD
Famotidine—Confusional state—Irinotecan—colon cancer	0.00365	0.00365	CcSEcCtD
Famotidine—Thrombocytopenia—Vincristine—colon cancer	0.00364	0.00364	CcSEcCtD
Famotidine—Haematuria—Capecitabine—colon cancer	0.00362	0.00362	CcSEcCtD
Famotidine—Oedema—Irinotecan—colon cancer	0.00362	0.00362	CcSEcCtD
Famotidine—Anaphylactic shock—Irinotecan—colon cancer	0.00362	0.00362	CcSEcCtD
Famotidine—Chest pain—Fluorouracil—colon cancer	0.00362	0.00362	CcSEcCtD
Famotidine—Myalgia—Fluorouracil—colon cancer	0.00362	0.00362	CcSEcCtD
Famotidine—Infection—Irinotecan—colon cancer	0.0036	0.0036	CcSEcCtD
Famotidine—Shock—Irinotecan—colon cancer	0.00356	0.00356	CcSEcCtD
Famotidine—Agranulocytosis—Capecitabine—colon cancer	0.00354	0.00354	CcSEcCtD
Famotidine—Thrombocytopenia—Irinotecan—colon cancer	0.00354	0.00354	CcSEcCtD
Famotidine—Anorexia—Vincristine—colon cancer	0.00354	0.00354	CcSEcCtD
Famotidine—Irritability—Methotrexate—colon cancer	0.0035	0.0035	CcSEcCtD
Famotidine—Confusional state—Fluorouracil—colon cancer	0.00349	0.00349	CcSEcCtD
Famotidine—Bradycardia—Capecitabine—colon cancer	0.00347	0.00347	CcSEcCtD
Famotidine—Anaphylactic shock—Fluorouracil—colon cancer	0.00347	0.00347	CcSEcCtD
Famotidine—Oedema—Fluorouracil—colon cancer	0.00347	0.00347	CcSEcCtD
Famotidine—Anorexia—Irinotecan—colon cancer	0.00345	0.00345	CcSEcCtD
Famotidine—Infection—Fluorouracil—colon cancer	0.00344	0.00344	CcSEcCtD
Famotidine—Hepatitis—Capecitabine—colon cancer	0.00341	0.00341	CcSEcCtD
Famotidine—Thrombocytopenia—Fluorouracil—colon cancer	0.00339	0.00339	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Vincristine—colon cancer	0.00339	0.00339	CcSEcCtD
Famotidine—Pharyngitis—Capecitabine—colon cancer	0.00338	0.00338	CcSEcCtD
Famotidine—Insomnia—Vincristine—colon cancer	0.00336	0.00336	CcSEcCtD
Famotidine—Paraesthesia—Vincristine—colon cancer	0.00334	0.00334	CcSEcCtD
Famotidine—Anorexia—Fluorouracil—colon cancer	0.0033	0.0033	CcSEcCtD
Famotidine—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.0033	0.0033	CcSEcCtD
Famotidine—Insomnia—Irinotecan—colon cancer	0.00327	0.00327	CcSEcCtD
Famotidine—Paraesthesia—Irinotecan—colon cancer	0.00325	0.00325	CcSEcCtD
Famotidine—Decreased appetite—Vincristine—colon cancer	0.00323	0.00323	CcSEcCtD
Famotidine—Erythema multiforme—Capecitabine—colon cancer	0.00322	0.00322	CcSEcCtD
Famotidine—Somnolence—Irinotecan—colon cancer	0.00322	0.00322	CcSEcCtD
Famotidine—Fatigue—Vincristine—colon cancer	0.0032	0.0032	CcSEcCtD
Famotidine—Dyspepsia—Irinotecan—colon cancer	0.00319	0.00319	CcSEcCtD
Famotidine—Tinnitus—Capecitabine—colon cancer	0.00318	0.00318	CcSEcCtD
Famotidine—Pain—Vincristine—colon cancer	0.00318	0.00318	CcSEcCtD
Famotidine—Constipation—Vincristine—colon cancer	0.00318	0.00318	CcSEcCtD
Famotidine—Flushing—Capecitabine—colon cancer	0.00316	0.00316	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00316	0.00316	CcSEcCtD
Famotidine—Decreased appetite—Irinotecan—colon cancer	0.00315	0.00315	CcSEcCtD
Famotidine—Insomnia—Fluorouracil—colon cancer	0.00313	0.00313	CcSEcCtD
Famotidine—Fatigue—Irinotecan—colon cancer	0.00312	0.00312	CcSEcCtD
Famotidine—Paraesthesia—Fluorouracil—colon cancer	0.00311	0.00311	CcSEcCtD
Famotidine—Constipation—Irinotecan—colon cancer	0.00309	0.00309	CcSEcCtD
Famotidine—Pain—Irinotecan—colon cancer	0.00309	0.00309	CcSEcCtD
Famotidine—Somnolence—Fluorouracil—colon cancer	0.00308	0.00308	CcSEcCtD
Famotidine—Dyspepsia—Fluorouracil—colon cancer	0.00305	0.00305	CcSEcCtD
Famotidine—Arrhythmia—Capecitabine—colon cancer	0.00305	0.00305	CcSEcCtD
Famotidine—Abdominal discomfort—Methotrexate—colon cancer	0.00304	0.00304	CcSEcCtD
Famotidine—Gastrointestinal pain—Vincristine—colon cancer	0.00304	0.00304	CcSEcCtD
Famotidine—Decreased appetite—Fluorouracil—colon cancer	0.00301	0.00301	CcSEcCtD
Famotidine—Alopecia—Capecitabine—colon cancer	0.00301	0.00301	CcSEcCtD
Famotidine—Pancytopenia—Methotrexate—colon cancer	0.00301	0.00301	CcSEcCtD
Famotidine—Mental disorder—Capecitabine—colon cancer	0.00299	0.00299	CcSEcCtD
Famotidine—Feeling abnormal—Irinotecan—colon cancer	0.00298	0.00298	CcSEcCtD
Famotidine—Dysuria—Methotrexate—colon cancer	0.00296	0.00296	CcSEcCtD
Famotidine—Neutropenia—Methotrexate—colon cancer	0.00296	0.00296	CcSEcCtD
Famotidine—Pain—Fluorouracil—colon cancer	0.00296	0.00296	CcSEcCtD
Famotidine—Gastrointestinal pain—Irinotecan—colon cancer	0.00296	0.00296	CcSEcCtD
Famotidine—Upper respiratory tract infection—Methotrexate—colon cancer	0.00295	0.00295	CcSEcCtD
Famotidine—Abdominal pain—Vincristine—colon cancer	0.00294	0.00294	CcSEcCtD
Famotidine—Body temperature increased—Vincristine—colon cancer	0.00294	0.00294	CcSEcCtD
Famotidine—Erectile dysfunction—Methotrexate—colon cancer	0.00292	0.00292	CcSEcCtD
Famotidine—Dysgeusia—Capecitabine—colon cancer	0.00291	0.00291	CcSEcCtD
Famotidine—Photosensitivity reaction—Methotrexate—colon cancer	0.00289	0.00289	CcSEcCtD
Famotidine—Back pain—Capecitabine—colon cancer	0.00287	0.00287	CcSEcCtD
Famotidine—Abdominal pain—Irinotecan—colon cancer	0.00286	0.00286	CcSEcCtD
Famotidine—Body temperature increased—Irinotecan—colon cancer	0.00286	0.00286	CcSEcCtD
Famotidine—Feeling abnormal—Fluorouracil—colon cancer	0.00286	0.00286	CcSEcCtD
Famotidine—Muscle spasms—Capecitabine—colon cancer	0.00285	0.00285	CcSEcCtD
Famotidine—Depression—Methotrexate—colon cancer	0.00282	0.00282	CcSEcCtD
Famotidine—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.0028	0.0028	CcSEcCtD
Famotidine—Urticaria—Fluorouracil—colon cancer	0.00275	0.00275	CcSEcCtD
Famotidine—Anaemia—Capecitabine—colon cancer	0.00274	0.00274	CcSEcCtD
Famotidine—Body temperature increased—Fluorouracil—colon cancer	0.00274	0.00274	CcSEcCtD
Famotidine—Hypersensitivity—Vincristine—colon cancer	0.00274	0.00274	CcSEcCtD
Famotidine—Haematuria—Methotrexate—colon cancer	0.0027	0.0027	CcSEcCtD
Famotidine—Hypersensitivity—Irinotecan—colon cancer	0.00267	0.00267	CcSEcCtD
Famotidine—Asthenia—Vincristine—colon cancer	0.00267	0.00267	CcSEcCtD
Famotidine—Syncope—Capecitabine—colon cancer	0.00266	0.00266	CcSEcCtD
Famotidine—Leukopenia—Capecitabine—colon cancer	0.00266	0.00266	CcSEcCtD
Famotidine—Agranulocytosis—Methotrexate—colon cancer	0.00264	0.00264	CcSEcCtD
Famotidine—Palpitations—Capecitabine—colon cancer	0.00262	0.00262	CcSEcCtD
Famotidine—Loss of consciousness—Capecitabine—colon cancer	0.00261	0.00261	CcSEcCtD
Famotidine—Asthenia—Irinotecan—colon cancer	0.0026	0.0026	CcSEcCtD
Famotidine—Cough—Capecitabine—colon cancer	0.00259	0.00259	CcSEcCtD
Famotidine—Hypersensitivity—Fluorouracil—colon cancer	0.00255	0.00255	CcSEcCtD
Famotidine—Diarrhoea—Vincristine—colon cancer	0.00254	0.00254	CcSEcCtD
Famotidine—Hepatitis—Methotrexate—colon cancer	0.00254	0.00254	CcSEcCtD
Famotidine—Chest pain—Capecitabine—colon cancer	0.00253	0.00253	CcSEcCtD
Famotidine—Myalgia—Capecitabine—colon cancer	0.00253	0.00253	CcSEcCtD
Famotidine—Arthralgia—Capecitabine—colon cancer	0.00253	0.00253	CcSEcCtD
Famotidine—Pharyngitis—Methotrexate—colon cancer	0.00252	0.00252	CcSEcCtD
Famotidine—Anxiety—Capecitabine—colon cancer	0.00252	0.00252	CcSEcCtD
Famotidine—Diarrhoea—Irinotecan—colon cancer	0.00248	0.00248	CcSEcCtD
Famotidine—Dry mouth—Capecitabine—colon cancer	0.00247	0.00247	CcSEcCtD
Famotidine—Dizziness—Vincristine—colon cancer	0.00246	0.00246	CcSEcCtD
Famotidine—Pruritus—Fluorouracil—colon cancer	0.00245	0.00245	CcSEcCtD
Famotidine—Confusional state—Capecitabine—colon cancer	0.00244	0.00244	CcSEcCtD
Famotidine—Oedema—Capecitabine—colon cancer	0.00242	0.00242	CcSEcCtD
Famotidine—Infection—Capecitabine—colon cancer	0.00241	0.00241	CcSEcCtD
Famotidine—Erythema multiforme—Methotrexate—colon cancer	0.0024	0.0024	CcSEcCtD
Famotidine—Dizziness—Irinotecan—colon cancer	0.00239	0.00239	CcSEcCtD
Famotidine—Shock—Capecitabine—colon cancer	0.00238	0.00238	CcSEcCtD
Famotidine—Diarrhoea—Fluorouracil—colon cancer	0.00237	0.00237	CcSEcCtD
Famotidine—Thrombocytopenia—Capecitabine—colon cancer	0.00237	0.00237	CcSEcCtD
Famotidine—Tinnitus—Methotrexate—colon cancer	0.00237	0.00237	CcSEcCtD
Famotidine—Vomiting—Vincristine—colon cancer	0.00236	0.00236	CcSEcCtD
Famotidine—Rash—Vincristine—colon cancer	0.00234	0.00234	CcSEcCtD
Famotidine—Dermatitis—Vincristine—colon cancer	0.00234	0.00234	CcSEcCtD
Famotidine—Headache—Vincristine—colon cancer	0.00233	0.00233	CcSEcCtD
Famotidine—Anorexia—Capecitabine—colon cancer	0.00231	0.00231	CcSEcCtD
Famotidine—Vomiting—Irinotecan—colon cancer	0.0023	0.0023	CcSEcCtD
Famotidine—Dizziness—Fluorouracil—colon cancer	0.00229	0.00229	CcSEcCtD
Famotidine—Rash—Irinotecan—colon cancer	0.00228	0.00228	CcSEcCtD
Famotidine—Dermatitis—Irinotecan—colon cancer	0.00228	0.00228	CcSEcCtD
Famotidine—Headache—Irinotecan—colon cancer	0.00227	0.00227	CcSEcCtD
Famotidine—Alopecia—Methotrexate—colon cancer	0.00224	0.00224	CcSEcCtD
Famotidine—Mental disorder—Methotrexate—colon cancer	0.00222	0.00222	CcSEcCtD
Famotidine—Nausea—Vincristine—colon cancer	0.00221	0.00221	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00221	0.00221	CcSEcCtD
Famotidine—Vomiting—Fluorouracil—colon cancer	0.0022	0.0022	CcSEcCtD
Famotidine—Insomnia—Capecitabine—colon cancer	0.00219	0.00219	CcSEcCtD
Famotidine—Rash—Fluorouracil—colon cancer	0.00219	0.00219	CcSEcCtD
Famotidine—Dermatitis—Fluorouracil—colon cancer	0.00218	0.00218	CcSEcCtD
Famotidine—Paraesthesia—Capecitabine—colon cancer	0.00217	0.00217	CcSEcCtD
Famotidine—Headache—Fluorouracil—colon cancer	0.00217	0.00217	CcSEcCtD
Famotidine—Dysgeusia—Methotrexate—colon cancer	0.00216	0.00216	CcSEcCtD
Famotidine—Nausea—Irinotecan—colon cancer	0.00215	0.00215	CcSEcCtD
Famotidine—Back pain—Methotrexate—colon cancer	0.00214	0.00214	CcSEcCtD
Famotidine—Dyspepsia—Capecitabine—colon cancer	0.00213	0.00213	CcSEcCtD
Famotidine—Decreased appetite—Capecitabine—colon cancer	0.00211	0.00211	CcSEcCtD
Famotidine—Fatigue—Capecitabine—colon cancer	0.00209	0.00209	CcSEcCtD
Famotidine—Constipation—Capecitabine—colon cancer	0.00207	0.00207	CcSEcCtD
Famotidine—Pain—Capecitabine—colon cancer	0.00207	0.00207	CcSEcCtD
Famotidine—Nausea—Fluorouracil—colon cancer	0.00206	0.00206	CcSEcCtD
Famotidine—Anaemia—Methotrexate—colon cancer	0.00204	0.00204	CcSEcCtD
Famotidine—Feeling abnormal—Capecitabine—colon cancer	0.002	0.002	CcSEcCtD
Famotidine—Gastrointestinal pain—Capecitabine—colon cancer	0.00198	0.00198	CcSEcCtD
Famotidine—Leukopenia—Methotrexate—colon cancer	0.00198	0.00198	CcSEcCtD
Famotidine—Cough—Methotrexate—colon cancer	0.00193	0.00193	CcSEcCtD
Famotidine—Urticaria—Capecitabine—colon cancer	0.00192	0.00192	CcSEcCtD
Famotidine—Abdominal pain—Capecitabine—colon cancer	0.00191	0.00191	CcSEcCtD
Famotidine—Body temperature increased—Capecitabine—colon cancer	0.00191	0.00191	CcSEcCtD
Famotidine—Convulsion—Methotrexate—colon cancer	0.00191	0.00191	CcSEcCtD
Famotidine—Arthralgia—Methotrexate—colon cancer	0.00188	0.00188	CcSEcCtD
Famotidine—Chest pain—Methotrexate—colon cancer	0.00188	0.00188	CcSEcCtD
Famotidine—Myalgia—Methotrexate—colon cancer	0.00188	0.00188	CcSEcCtD
Famotidine—Confusional state—Methotrexate—colon cancer	0.00182	0.00182	CcSEcCtD
Famotidine—Anaphylactic shock—Methotrexate—colon cancer	0.0018	0.0018	CcSEcCtD
Famotidine—Infection—Methotrexate—colon cancer	0.00179	0.00179	CcSEcCtD
Famotidine—Hypersensitivity—Capecitabine—colon cancer	0.00178	0.00178	CcSEcCtD
Famotidine—Thrombocytopenia—Methotrexate—colon cancer	0.00177	0.00177	CcSEcCtD
Famotidine—Asthenia—Capecitabine—colon cancer	0.00174	0.00174	CcSEcCtD
Famotidine—Anorexia—Methotrexate—colon cancer	0.00172	0.00172	CcSEcCtD
Famotidine—Pruritus—Capecitabine—colon cancer	0.00171	0.00171	CcSEcCtD
Famotidine—Diarrhoea—Capecitabine—colon cancer	0.00166	0.00166	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Methotrexate—colon cancer	0.00164	0.00164	CcSEcCtD
Famotidine—Insomnia—Methotrexate—colon cancer	0.00163	0.00163	CcSEcCtD
Famotidine—Paraesthesia—Methotrexate—colon cancer	0.00162	0.00162	CcSEcCtD
Famotidine—Somnolence—Methotrexate—colon cancer	0.0016	0.0016	CcSEcCtD
Famotidine—Dizziness—Capecitabine—colon cancer	0.0016	0.0016	CcSEcCtD
Famotidine—Dyspepsia—Methotrexate—colon cancer	0.00159	0.00159	CcSEcCtD
Famotidine—Decreased appetite—Methotrexate—colon cancer	0.00157	0.00157	CcSEcCtD
Famotidine—Fatigue—Methotrexate—colon cancer	0.00155	0.00155	CcSEcCtD
Famotidine—Pain—Methotrexate—colon cancer	0.00154	0.00154	CcSEcCtD
Famotidine—Vomiting—Capecitabine—colon cancer	0.00154	0.00154	CcSEcCtD
Famotidine—Rash—Capecitabine—colon cancer	0.00153	0.00153	CcSEcCtD
Famotidine—Dermatitis—Capecitabine—colon cancer	0.00153	0.00153	CcSEcCtD
Famotidine—Headache—Capecitabine—colon cancer	0.00152	0.00152	CcSEcCtD
Famotidine—Feeling abnormal—Methotrexate—colon cancer	0.00149	0.00149	CcSEcCtD
Famotidine—Gastrointestinal pain—Methotrexate—colon cancer	0.00147	0.00147	CcSEcCtD
Famotidine—Nausea—Capecitabine—colon cancer	0.00144	0.00144	CcSEcCtD
Famotidine—Urticaria—Methotrexate—colon cancer	0.00143	0.00143	CcSEcCtD
Famotidine—Body temperature increased—Methotrexate—colon cancer	0.00143	0.00143	CcSEcCtD
Famotidine—Abdominal pain—Methotrexate—colon cancer	0.00143	0.00143	CcSEcCtD
Famotidine—Hypersensitivity—Methotrexate—colon cancer	0.00133	0.00133	CcSEcCtD
Famotidine—Asthenia—Methotrexate—colon cancer	0.00129	0.00129	CcSEcCtD
Famotidine—Pruritus—Methotrexate—colon cancer	0.00128	0.00128	CcSEcCtD
Famotidine—Diarrhoea—Methotrexate—colon cancer	0.00123	0.00123	CcSEcCtD
Famotidine—Dizziness—Methotrexate—colon cancer	0.00119	0.00119	CcSEcCtD
Famotidine—Vomiting—Methotrexate—colon cancer	0.00115	0.00115	CcSEcCtD
Famotidine—Rash—Methotrexate—colon cancer	0.00114	0.00114	CcSEcCtD
Famotidine—Dermatitis—Methotrexate—colon cancer	0.00114	0.00114	CcSEcCtD
Famotidine—Headache—Methotrexate—colon cancer	0.00113	0.00113	CcSEcCtD
Famotidine—Nausea—Methotrexate—colon cancer	0.00107	0.00107	CcSEcCtD
